Scott Eckstein Tim Regan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NeonMind Unveils Initial Treatment Offering at Specialty Mental Health Clinic in Mississauga

Press release content from Accesswire. The AP news staff was not involved in its creation.

Rob tessaroloScott eckstein tim reganStrategic communicationsNeonmind biosciences incCanadian securities exchangeAnxiety disordersRecommended treatmentCanadian guidelinesUpon clinicNeonmind biosciencesSite medical directorChief executive officerMental health

NeonMind Biosciences Inc : NeonMind Unveils Initial Treatment Offering at Specialty Mental Health Clinic in Mississauga

To Deliver Low Dose Intravenous Ketamine for Mood and Anxiety Disorders, a Recommended Treatment by Canadian Guidelines, Upon Clinic LicensingOAKVILLE, ON / ACCESSWIRE / March 23, 2022 / NeonMind Biosciences

Rob tessaroloScott eckstein tim reganStrategic communicationsNeonmind biosciences incCanadian securities exchangeAnxiety disordersRecommended treatmentCanadian guidelinesUpon clinicNeonmind biosciencesSite medical directorChief executive officer

NeonMind Biosciences Inc : NeonMind Announces Positive Preclinical Results Demonstrating the Efficacy of Psilocybin in Reducing Weight Gain in Obese Animal Subjects

Data Further Validates Psilocybin as a Drug Candidate for Obesity and Supports Development of NeonMind's Drug Programs NEO-001 and NEO-002OAKVILLE, ON / ACCESSWIRE / March 23, 2022 / NeonMind Biosciences

Alasdair barrRob tessaroloScott eckstein tim reganRobert tessaroloStrategic communicationsNeonmind biosciences incDevelopment of neonmind drug programsCanadian securities exchangeData further validates psilocybinDrug candidateSupports developmentDrug programsNeonmind biosciencesChief executive officer

NeonMind Biosciences Inc : NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss

OAKVILLE, ON / ACCESSWIRE / March 22, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind' or the "Company"), an integrated drug development and wellness company focused on bringing

United statesRob tessaroloScott eckstein tim reganRobert tessaroloTrademark officeStrategic communicationsNeonmind biosciences incCanadian securities exchangeNeonmind biosciencesUnited states patentChief executive officer

NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss

NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRob tessaroloScott eckstein tim reganRobert tessaroloTrademark officeStrategic communicationsNeonmind biosciences incCanadian securities exchangeNeonmind biosciencesUnited states patentChief executive officer